The appearance of multiresistant strains of Klebsiella in hospitals has been clearly associated with the widespread use of antimicrobial agents (12, 13, 16, 17) . Strains of Klebsiella isolated from healthy individuals who had no association with hospitals were shown by Davis and Matsen (5) to be resistant only to ampicillin and carbenicillin. By contrast, these workers found that strains carried by hospital patients in the same city were frequently resistant to many other antibiotics and often possessed transmissible R-factors.
Until recently even multiresistant hospital strains ofKlebsiella have retained their susceptibility to gentamicin. There have been few reports of gentamicin-resistant KIebsiella causing outbreaks of nosocomial infection (8, 10) . In these cases the gentamicin resistance was transferable from the Klebsiella to recipient laboratory strains of Escherichia coli. In our own hospital, gentamicin was used for 7 years before the first gentamicin-resistant strains of Klebsiella appeared. The present report gives an account of their emergence and spread and describes the main characteristics of the gentamicin-resistant strains.
MATERIALS AND METHODS
Identification and typing ofKlebsiella. All of the Klebsiella studied were clinical isolates from inpatients at Sunnybrook Medical Centre, Toronto, which is a 1,000-bed teaching hospital with almost equal numbers of acute and chronic patients. Isolates were first identified in the diagnostic laboratory as Klebsiella species by standard methods (7) . The capsular serotypes of gentamicin-resistant isolates were determined by quellung reaction by the method reported by Casewell (3). Typing antisera against the 72 recognized capsular types of Klebsiella were prepared by immunizing rabbits and were absorbed to remove cross-reacting antibodies (7) . The gentamicin-resistant Klebsiella were further subdivided by the numerical biotyping scheme that we described previously (14) . The results of the two typing methods were combined as the serobiotype of the strain, and this provided a more discriminating system for differentiating Klebsiella than did either typing method used alone.
Antimicrobial susceptibility testing. Routine susceptibility tests were done in the diagnostic laboratory by inoculating isolates with a Steers inocula replicator to Mueller-Hinton agar (BBL) plates containing antimicrobials in the following concentrations: chloramphenicol (Ch), 16 ug/ml; tetracycline (Te), 4 ,ug/ml; cephalothin (Ce), 16 ug/ml; ampicillin (A), 16 ,g/ml; carbenicillin (Ca), 100 ug/ml; colistin (Co), 10 ,ug/ml; nalidixic acid (Na), 12 ,tg/ml; nitrofurantoin (Ni), 30 jug/ml; sulfamethoxazole (Su), 10 Ag/ml; kanamycin (K), 8 ,g/ml; and gentamicin (G), 4 ,ug/ml. Isolates not inhibited at these concentrations were considered resistant for the purposes of clinical reporting. Isolates not inhibited by 4 ,ug of gentamicin per ml had full minimal inhibitory concentration (MIC) estimations performed for gentamicin, streptomycin (Str), neomycin (Ne), kanamycin, tobramycin (To), sisomicin (Si), amikacin, and netilmicin (an experimental semisynthetic aminoglycoside developed by Schering Corp. and origi-ANTIMICROB. AGENTS CHEMOTHER. nally designated Sch 20569). Serial two fold dilutions ofthe antibiotics were made so that their final concentrations in Mueller-Hinton agar ranged from 0.25 to 128 ug/ml. The inoculum for MIC estimations was an 18-h broth culture diluted in saline to contain 2 x 107 bacteria/ml; the number transferred by the inocula replicator to each plate was approximately 1 x 105 organisms.
Cephalosporinase activity of Klebsiella isolates was determined qualitatively by a modification of an iodometric method (9, 11) with cephalothin (2.5 mg/ml) as the substrate. The reaction mixture consisted of 1 ml of cephalothin solution and 1 ml of an overnight broth culture of Klebsiella. After 2 h of incubation at 37°C, 0.4 ml of iodine reagent and 0. Table 1 , use of the antibiotic in our hospital has increased steadily since. In the 6-year period from January 1968 to March 1974, gentamicin-resistant Klebsiella were not isolated from patients in the hospital. Then, from April 1974 to the end of 1975, 98 gentamicinresistant Klebsiella were found among a total of 2,300 isolates identified as Klebsiella species in our laboratory. These resistant strains were isolated from 35 patients on nine different wards. They were found only in urine specimens in 23 of the 35 cases, only in sputum in 4 cases, in wound specimens in 2 cases, and in blood cultures in 2 cases. In the other four patients, the resistant Klebsiella were isolated from more than one body site, but both urinary and respiratory tracts were involved in each case.
The gentamicin-resistant Klebsiella were subdivided by combined typing into eight distinct serobiotypes ( Table 2 ). The 27 isolates obtained from five patients did not react with any of our 72 monospecific antisera of the international set, but did give positive quellung reactions with an antiserum (labeled SK1) prepared by immunizing rabbits with one of these isolates. Two other strains did not type with the standard antisera or with antiserum SK1. These two strains, NT:4/3/4 and NT:1/1/1, were differentiated from each other by their biotypes and from other isolates by the combination of biotype and failure to react with any of the antisera. Table 2 shows that four of the resistant serobiotyes were isolated from only one patient each and that serobiotypes SK1:1/1/1, NT:4/3/4, and K45:1/1/2 each infected only a very small number of patients over a relatively short period of time. We also found that these strains did not spread from one ward to another.
By contrast, gentamicin-resistant Klebsiella of serobiotype K22:1/1/2 have persisted in the hospital for almost 2 years since they were first isolated in April 1974. In all, gentamicin-resistant type 22 Klebsiella with indistinguishable biochemical characteristics were isolated from 20 patients on five different wards. One strain of serobiotype K22:1/1/2 differed from the other 19 strains, which were entirely homogeneous in their antibiotic susceptibilities, in having much lower MICs for tetracycline, neomycin, and sulfonamide than the others and a higher amikacin MIC. It also had no detectable cephalosporinase activity, whereas the others all did. It was therefore considered to be distinct from the other type 22 Klebsiella and was designated subsequently as K22:1/1/2 (P).
The 19 identical K22:1/1/2 Klebsiella were associated with two distinct episodes of cross- Table 3 shows the association ofbladder catheterization and the acquisition of gentamicinresistant Klebsiella. Of the 27 patients from whom urinary isolates were obtained, 22 had an indwelling catheter in place when the strain was isolated, 1 had been catheterized shortly before, and 4 were seriously debilitated patients with no history of bladder instrumentation. Both patients with bacteremia had bladder catheters in place when the Klebsiella was isolated from blood cultures, and this is a probable route of entry of the organisms. However, urine samples were not submitted at the times that would have been necessary to prove a urinary infection by the organism. Two of the four patients with resistant Klebsiella in their sputum were intubated and received frequent bronchial suction, one had recent anesthesia with intubation, and the last had no respiratory manipulations but was in the terminal stage of bronchogenic carcinoma. All except 2 of the 35 patients infected with gentamicin-resistant Klebsiella had received antibiotics prior to their acquisition of the strain; only 11 (Table 2) , these resistances were never cotransferred.
Origin of gentamicin-resistantKlebsielka at Sunnybrook Medical Centre. About a month before the appearance of the first gentamicinresistant Klebsiella, which was of serobiotype K22:1/1/2, a gentamicin-susceptible strain (MIC = 0.5 ,g/ml) was isolated from a catheter urine and the amputation wound of another patient on the same chronic care ward. The serobiotype of this strain ofKlebsiella was also K22:1/1/2; it was resistant to ampicillin, carbenicillin, nitrofurantoin, kanamycin, neomycin, and streptomycin and susceptible to other antimicrobials.
To determine whether the gentamicin-susceptible type 22 Klebsiella was capable of ac- quiring an R-factor, a gentamicin-resistant E. coli transconjugant, recovered from the mating of the first resistant type 22 Klebsiella with the E. coli recipient strain, was used as a donor culture and was mated with the gentamicinsusceptible type 22 Klebsiella. "Laboratory-derived" gentamicin-resistant type 22 Klebsiella, with cotransferred resistance to chloramphenicol, tetracycline and tobramycin, were recovered after the mixed culture was plated on selective media containing gentamicin (4 ug/ ml) and ampicillin (16 gtg/ml). This laboratoryderived strain was then found to be capable of transferring its gentamicin resistance to the original E. coli recipient.
Activity of other aminoglycosides against gentamicin-resistant Klebsiella. All of the strains had kanamycin MICs > 64 ,ug/ml, and all had neomycin MICs > 128 ,tg/ml, except for the single strain of K22:1/1/2 (P) which had an MIC of 8 ,ug/ml. The tobramycin MIC of every strain was consistently the same as its gentamicin MIC. Resistance to streptomycin varied with different serobiotypes. Types SK1, K45, K9, and K21 had streptomycin MICs < 8 ,ug/ ml, whereas the MICs of the other five types were all >128 ,g/ml. Sisomicin MICs ranged from 4 to 16 ,g/ml with all of the types of Klebsiella. All serobiotypes had amikacin MICs of 1 to 2 ,ug/ml, except for the K22:1/1/2 (P) strain which had an MIC of 16 ,g/ml. Netilmicin showed the lowest MICs of all the aminoglycosides tested. All of the gentamicin-resistant Klebsiella had netilmicin MICs of 0.25 or 0.5 ,ug/ml.
DISCUSSION
Despite the increasing use of gentamicin in our hospital since it was first introduced about 8 years ago, gentamicin resistance has been slow to develop in strains ofKlebsiella isolated in the institution. Other workers (10) have suggested that the incidence of gentamicin-resistant Klebsiella may be directly related to the amount of the antibiotic used in a hospital, but we did not find any obvious association between gentamicin usage and the number of resistant Klebsiella we isolated (Table 1) . Most of the resistant strains failed to spread in the hospital. The small outbreaks of infection that did occur were largely the result of case-to-case spread of urinary tract infections on individual wards, sometimes following the transfer of an infected patient from one ward to another.
It is probable that the emergence of gentamicin-resistant Klebsiella in our hospital resulted from the in vivo acquisition of an R-factor by a strain previously susceptible to gentamicin. This strain was of an identical serobiotype (K22:1/1/2) to that of the first gentamicin-resistant Klebsiella; it was isolated earlier on the same ward, and it was shown to be capable of acquiring an R-factor mediating gentamicin resistance. Only gentamicin-resistant type 22 Klebsiella were isolated from the index case ( Fig. 1) and, therefore, the exact sequence of events that led to the R-factor acquisition could not be determined. However, transferable gentamicin resistance has been described in other bacteria found commonly in hospitals (2, 15, 18), and it seems likely that the source of the Rfactor for gentamicin resistance in this Klebsiella was another enteric bacterium.
Of particular clinical significance was the observation that the resistant type 22 Klebsiella, the strain with a known gentamicin-susceptible precursor, was the only strain that persisted for more than a few months. This strain was also one in which the R-factor for gentamicin resistance appeared to lose its conjugative capacity and was not detected either after the strain had cross-infected a number of patients or when it reemerged in a different area of the hospital after a latent period of several months. We did not attempt transfer-enhancing techniques and, therefore, we cannot say with absolute certainty that the R-factor in the later type 22 isolates had become nonconjugative. However, even if the R-factor in these later isolates was conjugative, but at levels too low to detect by our simple methods, these findings still raise the question of the stability and survival advantage of this kind of strain over other strains possessing R-factors that transfer them at higher frequencies. In another study it was shown, even if somewhat artificially, that enterobacteria carrying transferable R-factors survived less readily in the gut than strains which appeared to be R-factor free (1). It may well be that the gentamicin-resistant type GENTAMICIN-RESISTANT KLEBSIELLA 183
22 Klebsiella is peculiar in having a mechanism which assists its ability to survive by suppressing the frequency of R-factor transfer, deletion of an undesirable portion of an R-factor, or stable integration into the chromosome. Further studies will be required to determine whether one of these mechanisms is operating in this strain. Our resistant Klebsiella have not yet been tested for gentamicin-inactivating enzyme activity, and therefore we cannot discount other mechanisms of inactivation ofthe antibiotic (4). However, an enzymatic mechanism seems the most probable, particularly as kanamycin, tobramycin, and neomycin, but not other aminoglycosides, were cotransferred in every strain that transferred its gentamicin resistance. Since the specificity of an aminoglycoside-3'-transferase has been shown to reside in these substrates (6) , it will be necessary to have our strains examined for such an enzymatic mechanism ofgentamicin inactivation. The likelihood of finding a single enzyme responsible for Rfactor-mediated gentamicin resistance in our Klebsiella seems quite high and could have significant epidemiological implications for other enterobacteria in our hospital that are capable of acquiring R-factors.
Of all the aminoglycosides tested, only amikacin and netilmicin inhibited all of the gentamicin-resistant Klebsiella at levels that can be achieved in the blood with normal doses. In particular, every strain was highly susceptible to netilmicin. Streptomycin and sisomicin MICs were variable, depending on the strain or serobiotype isolated. All of the gentamicin-resistant strains were susceptible to colistin and nalidixic acid. However, as both of these have definite therapeutic limitations, the efficacy of amikacin and netilmicin against gentamicinresistant Klebsiella is likely to be of real clinical importance in the future.
